PHS
EXAS

PFM Health Sciences’s Exact Sciences EXAS Stock Holding History

PFM Health Sciences’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-161,679
Closed -$14.1M – 82
2020
Q2 		$14.1M Buy
+161,679
New +$12.9M 0.73% 51
2020
Q1 		– Sell
-209,839
Closed -$19.4M – 68
2019
Q4 		$19.4M Buy
+209,839
New +$18.4M 0.92% 37
2019
Q3 		– Sell
-418,329
Closed -$49.4M – 82
2019
Q2 		$49.4M Sell
418,329
-148,030
-26% -$14.9M 0.94% 38
2019
Q1 		$49.1M Buy
+566,359
New +$48.2M 1.08% 33
2015
Q2 		– Sell
-1,331,742
Closed -$29.3M – 97
2015
Q1 		$29.3M Buy
+1,331,742
New +$33.8M 0.81% 48
2013
Q3 		– Sell
-480,401
Closed -$6.68M – 80
2013
Q2 		$6.68M Buy
+480,401
New +$5.22M 0.14% 63

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

PFM Health Sciences's EXAS Position: Q3 2020 in Review

PFM Health Sciences sold out of Exact Sciences (EXAS) in Q3 2020, closing a stake of 161,679 shares — an estimated $14.1M sold.

PFM Health Sciences first reported a position in EXAS in Q2 2013 and held it in 6 quarters. The position peaked at $49.4M in Q2 2019. 517 funds tracked by Wall St. Rank hold EXAS as of Q3 2020.

  • PFM Health Sciences reported no remaining Exact Sciences position as of Q3 2020 after selling out during the quarter.
  • PFM Health Sciences sold 161,679 Exact Sciences shares in Q3 2020, an estimated $14.1M.
  • PFM Health Sciences first reported a position in Exact Sciences in Q2 2013 and held it in 6 quarters.
  • PFM Health Sciences's Exact Sciences position peaked at $49.4M in Q2 2019.
  • 517 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2020.

Based on PFM Health Sciences's 13F filing for Q3 2020, filed 16 Nov 2020.